Literature DB >> 12842710

Hemangioblastic characteristics of fetal bone marrow-derived Flk1(+)CD31(-)CD34(-) cells.

Hong Guo1, Baijun Fang, Lianming Liao, Zhigang Zhao, Jiewen Liu, Huishu Chen, Steven H Hsu, Qi Cui, Robort Chunhua Zhao.   

Abstract

OBJECTIVE: To investigate whether Flk1(+)CD31(-)CD34(-) cells isolated from fetal bone marrow (BM) have characteristics of hemangioblasts, i.e., progenitors of endothelial and hematopoietic cells.
MATERIALS AND METHODS: Mononuclear cells from fetal BM were negatively sorted by CD45, GlyA, and CD34 micromagnetic beads, then cultured to form cell colonies. A single colony was harvested. Culture-expanded cells were seeded on ECM gel or semisolid media supplemented with endothelial and hematopoietic growth factors, respectively. Immunochemistry staining and RT-PCR were performed for cell characterization.
RESULTS: 99% of cells from the single colony maintained Flk1(+) and CD31/CD34(-) during passaging. On ECM gel, Flk1(+)CD31(-)CD34(-) cells could grow into vascular structure that was positive for CD31 and vWF. There were round CD34(+) cells around the vascular structure. When angiogenesis inhibitor suramin was added before tube formation, formation of vascular structure was blocked. Additionally, Flk1(+)CD31(-)CD34(-) cells cultured on hematopoietic condition could differentiate into hematopoietic cells which expressed GATA-1, 2, and gamma, beta globin gene. After being replated in methylcellulose medium, they formed typical erythroid colonies.
CONCLUSIONS: Flk1(+)CD31(-)CD34(-) cells derived from fetal BM could differentiate into endothelial and hematopoietic cells. The results suggested that these Flk1(+)CD31(-)CD34(-) cells after embryo stage bear characteristics of hemangioblast and may have potential application for the hematopoietic and vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842710     DOI: 10.1016/s0301-472x(03)00087-0

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  13 in total

1.  BCR/ABL oncogene-induced PI3K signaling pathway leads to chronic myeloid leukemia pathogenesis by impairing immuno-modulatory function of hemangioblasts.

Authors:  Q Li; Y Wu; S Fang; L Wang; H Qi; Y Zhang; J Zhang; W Li
Journal:  Cancer Gene Ther       Date:  2015-04-03       Impact factor: 5.987

Review 2.  Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.

Authors:  Gregor Prindull
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  The initial fetal human retinal vasculature develops by vasculogenesis.

Authors:  D Scott McLeod; Takuya Hasegawa; Tarl Prow; Carol Merges; Gerard Lutty
Journal:  Dev Dyn       Date:  2006-12       Impact factor: 3.780

4.  Pluripotent stem cells exhibiting similar characteristics can be isolated from human fetal bone marrow, heart, liver, muscle, lung, derma, kidney, and fat.

Authors:  Baijun Fang; Yongping Song; Chunhua Zhao; Mingxia Shi; Quande Lin
Journal:  Front Med China       Date:  2007-02-01

5.  Molecular biological characteristics of the recruitment of hematopoietic stem cells from bone marrow niche in chronic myeloid leukemia.

Authors:  Biao Zhu; Jianbo Zhang; Jiao Chen; Chenglong Li; Xiaodong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers.

Authors:  Yutaka Fujiki; Kirby L Johnson; Inga Peter; Hocine Tighiouart; Diana W Bianchi
Journal:  Biol Reprod       Date:  2009-03-11       Impact factor: 4.285

7.  The embryonic human choriocapillaris develops by hemo-vasculogenesis.

Authors:  Takuya Hasegawa; D Scott McLeod; Imran A Bhutto; Tarl Prow; Carol A Merges; Rhonda Grebe; Gerard A Lutty
Journal:  Dev Dyn       Date:  2007-08       Impact factor: 3.780

Review 8.  Stem cell research in China.

Authors:  Lianming Liao; Lingsong Li; Robert Chunhua Zhao
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-06-29       Impact factor: 6.237

9.  The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes.

Authors:  Zhigang Zhao; Zhenling Wang; Qiubai Li; Weiming Li; Yong You; Ping Zou
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

10.  The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes.

Authors:  Zhenling Wang; Xiaoqiong Tang; Wen Xu; Zeng Cao; Li Sun; Weiming Li; Qiubai Li; Ping Zou; Zhigang Zhao
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.